About us
Our purpose
To tackle the greatest healthcare challenges of our time
Our ambition
To build the world's most valuable metabolic health pipeline — delivering value for patients, partners, and providers — for generations to come
We are a metabolic health company with a focus on the therapeutic areas of obesity, rare disease, and chronic inflammation
For more than 25 years, Zealand Pharma has pushed the boundaries of metabolic health science. Building on our core expertise in the discovery, design and development of therapeutic peptides and other modalities, we are advancing therapies that target key drivers and consequences of impaired metabolic health, including obesity, rare diseases and chronic inflammation.
In obesity, our capabilities place us in a unique position to address the greatest healthcare challenges of our time and positively impact hundreds of millions of lives. Within rare diseases, we have a long-standing commitment to deliver new treatments to people living with congenital hyperinsulinism and short bowel syndrome. For chronic inflammatory diseases, we are progressing peptide programs focused on high-profile targets shown to be difficult to address with small molecules and antibodies.
Our strategy is to pursue global co-development and commercialization partnerships that complement and extend our capabilities across the value chain, enabling us to deliver new treatment options to patients that enhance life, not restrict it.
27
years in peptide research and development
500+
employees across Denmark and the United States
80%
employees working in R&D and related functions
8+
innovative pipeline candidates targeting metabolic health
Our Zealand DNA
Throughout our 25-year history, we have built a unique company culture where employees are given autonomy to shape their work with a strong focus on a deeper purpose. We live this every day by leveraging our DNA.
We are BOLD. We EMPOWER people. We work as ONE team. We can be TRUSTED.
Meet Zealand's Co-Founder
Hear from one of our co-founders, Bjarne Due Larsen, as he shares his experience of growing up, discovering his love of science, and his path to the founding of Zealand Pharma.
-
Peptide expertise
We have more than 25 years of expertise in discovery, design and development of peptide-based medicines.
-
Partnerships
We engage with partners so that we can focus on our core competencies.
-
Our impact
We have a responsibility to society, our employees, and the environment.
